Have a personal or library account? Click to login
Clinical correlation of positive direct antiglobulin tests in patients with sickle cell disease Cover

Clinical correlation of positive direct antiglobulin tests in patients with sickle cell disease

Paid access
|Dec 2020

References

  1. Petz LD, Yam P, Wilkinson L, Garratty G, Lubin B, Mentzer W. Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood 1984;64:301—4.10.1182/blood.V64.1.301.301
  2. Chaplin H, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981;141:1091-3.10.1001/archinte.1981.00340080127029
  3. Mann JR, Cotter KP, Walker RA, Bird GWG, Stuart J. Anemic crisis in sickle cell disease. J Clin Pathol 1975;28:341-4.10.1136/jcp.28.5.341
  4. Maniatis A, Bertles JF, Wethers DL. Cold agglutinins and sickle-cell disease. Lancet 1977;1:50.10.1016/S0140-6736(77)91692-0
  5. Ward PCJ, Smith CM, White JG. An unusual morphologic finding in a case of sickle-cell anemia with intercurrent cold-agglutinin syndrome. Am J Clin Pathol 1979;72:479-85.10.1093/ajcp/72.3.479474528
  6. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94-8.10.1046/j.1537-2995.1987.27187121485.x3810834
  7. Chan-Shu SA. The second example of anti-Duffy. Transfusion 1980;20:358-60.10.1046/j.1537-2995.1980.20380214907.x7385332
  8. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest 1972;51:575-82.10.1172/JCI1068463021634536807
  9. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J Clin Invest 1972;51: 583-9.10.1172/JCI1068473021644622104
  10. Walker RH. Technical manual. 10th ed. Arlington, VA: American Association of Blood Banks, 1990.
  11. Krutrache M, Sirisinha S, Pacharee P, Chandanayingyong D. An association between thalassemia and autoimmune hemolytic anemia (AIHA). Scand J Haematol 1980;25:259-63.10.1111/j.1600-0609.1981.tb01398.x7466313
  12. Cividalli G, Sandler SG, Yatziv S, Engelhard D, Rachmilewitz N, Rachmilewitz EA. Beta-O-thalassemia complicated by autoimmune hemolytic anemia. Acta Haematologica 1980;63:37-43.10.1159/0002073666768208
  13. Forty E, Cartron J, Gire R, Girot R. Autoimmune hemolytic anemia complicating homozygotic beta-thalassemia. Arch Franc Ped 1986;43:261-2.
  14. Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 1991;77:214-37.10.1182/blood.V77.2.214.214
  15. Basu MK, Lee MM, Maniatis A, Bertles JF. Characteristics of I and i antigen receptors on the membrane of erythrocytes in sickle cell anemia. J Lab Clin Med 1984;103:712-19.
  16. Maniatis A, Papayannopoulou T, Bertles JF. Fetal characteristics of erythrocytes in sickle cell anemia: an immunofluorescence study of individual cells. Blood 1979;54:159-68.10.1182/blood.V54.1.159.159
  17. Wenz B, Gurtinger K, Wheaton D, Dugan EP. A mimicking red blood cell autoantibody accompanying transfusion and alloimmunization. Transfusion 1982;22:147–50.10.1046/j.1537-2995.1982.22282177123.x6803409
  18. Crosby WH, Rappaport H. Reticulocytopenia in autoimmune hemolytic anemia. Blood 1956;11:929-36.10.1182/blood.V11.10.929.929
  19. Orlina AR, Unger PJ, Koshy M. Posttransfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978;5:101-6.10.1002/ajh.2830050204104621
  20. Sarnaik S, Schornack J, Lusher JM. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986;26:249-52.10.1046/j.1537-2995.1986.26386209381.x3705143
  21. Mollison PL. Blood transfusion in clinical medicine. 8th ed. Oxford, England: Blackwell Scientific, 1987:363-5.
  22. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone, 1980:318-21.
  23. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion 1981;21:462-6.10.1046/j.1537-2995.1981.21481276005.x7268873
  24. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1→3)-linked galactose residues. J Exp Med 1985;162:573-82.10.1084/jem.162.2.57321877332410529
  25. Galili U, Clark MR, Shohet SB. Excessive binding of natural anti-alpha-galactosyl immunoglobulin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 1986;77:27-33.10.1172/JCI1122864233033944254
  26. Galili U, Korkesh A, Kahane I, Rachmilewitz EA. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood 1983;61:1258-64.10.1182/blood.V61.6.1258.1258
  27. Schluter K, Drenckhahn D. Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes. PNAS 1986;83:6137-41.10.1073/pnas.83.16.61373864543461480
  28. Ofosu MD, Saunders DA, Dunston GM, Castro O, Alarif L. Association of HLA and autoantibody in transfused sickle cell disease patients. Am J Hematol 1986;22:27-33.10.1002/ajh.28302201053082186
DOI: https://doi.org/10.21307/immunohematology-2019-975 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 13 - 16
Published on: Dec 6, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 R.L. Comenzo, M.E. Malachowski, E.M. Berkman, published by American National Red Cross
This work is licensed under the Creative Commons License.